US contract manufacturer West Pharmaceutical Services has purchased French device firm Plastef Investissements’ drug delivery business, adding the eris safety syringe system to its offering.
US contract services firm Norwich Pharmaceuticals has teamed up with Emerson Resources in a partnership that both claim will help drug industry partners bring products to market.
Singapore-based Industrial cleanroom and containment specialist Esco Micro has rolled out the latest generation of its Pharmacon Downflow booths for pharmaceutical sampling, grinding, dispensing and filling operations.
Novartis and Jubilant Organosys are among several companies forced to recall generic drugs after manufacturing operations at their shared CMO, India’s MJ Biopharm, were found to be in breach of GMP guidelines.
Ultrasonic particle engineering specialist Prosonix has been accredited under the ISO 9001:2008 quality scheme, after an inspection by the UK unit of independent auditing group SGS.
Novasep has bolstered its upstream processing capabilities by acquiring Henogen, a Belgium-based CMO that has biotech development and cGMP manufacturing expertise.
Northern Irish pack testing specialist Sepha has moved forward with plans to enter the Japanese market, showcasing its BlisterScan platform at Interphex Japan in Tokyo last week.
The USP is revising monographs of four pharmaceutical excipients in light of hazards associated with diethylene glycol contamination and is seeking comments from interested parties.
Altus Pharmaceuticals has terminated its contract with Lonza over an alleged breach in the agreement to provide active pharmaceutical ingredients (API) for Trizytek (liprotamase).
Particle Sciences (PSI) is aiming to advance its contract processing offering by collaborating with Microfluidics and sharing formulation and nanotechnology expertise.
US group Thermo Fisher Scientific and industrial engineering giant Siemens have teamed up to offer the pharmaceutical industry a new way of assessing processes used during early drug development, manufacturing scale up and commercial production.
US raw materials supplier Originates has boosted its pharmaceutical bovine hide gelatin manufacturing capacity with the addition of two new ISO 9000/9001 certified, GMP-standard production facilities in South America.
Quotient Bioresearch has agreed to acquire Amersham Radiolabelling Services and construct a new facility, expanding its radiochemical synthesis, testing and clinical studies offering.
US Marshals have seized products from Caraco’s facilities in Michigan because of concerns over cGMP compliance, which has led to Sun Pharma withdrawing its financial guidance.
US contract services firm KBI Biopharma has begun using the PER.C6 platform for cell line generation as part of its offering to meet growing demand for biomanufacturing services.
KV Pharmaceutical found deficiencies and instances of noncompliance during its internal investigation, which was launched in response to issues with the FDA and allegations of management misconduct.
Sanyo Biomedical and Environmental Solutions claims the H202 steralisation approach used by its Steisonic CxP MCO-19AIC(UVH) cell incubator system is an industry first and effective replacement for ethylene oxide (EtO).
US contractor Azopharma has added new GMP quality cytotoxics and high-potency manufacturing capacity at its facility in Hollywood, South Florida in a bid to strengthen its position in the trial materials sector.
Sigpack Systems, a subsidiary of Bosch Packaging Technology, claims its new toploader unit will both improve the efficiency and cut the cost of handling delicate pharmaceutical packaging.
Millipore has ramped up capacity for its Mobius range of single use bio-processing and manufacturing technologies with a new purpose built production facility in Danvers, Massachusetts.
German aseptic filling specialist Vetter has boosted packaging operations at its new facility in Ravensburg to meet growing demand for cost-effective secondary packaging services
Swiss life sciences solutions firm Lonza has been contracted by US biotechnology group Elusys Therapeutics to produce Anthim, its late stage Ab candidate treatment for anthrax infection.
Sanofi-Aventis is using SCM Pharma’s aseptic fill/finish service for radiolabelled compounds to manufacture an oncology product that is in clinical trials.
Sweden’s Alfa Laval says ART PR49, its combined chemical reactor and heat transfer plate, improves the efficiency of chemical production and helps reduce energy costs.
The US Federal Trade Commission (FTC) believes that an effective FOB approval pathway and laws preventing “pay-for-delay” deals are the only ways of reducing the cost of biologic drugs.
Demand for biopharmaceutical contract manufacturing will grow 16 per cent a year over the next five years, according to analysis by US market research group HighTech Business Decisions.
US contractor Velesco Pharmaceutical Services has leased a new clinical trial materials manufacturing facility in Kalamazoo, Michigan, extending its range of preclinical and early trial development services.
Commonwealth Biotechnologies (CBI) is set to acquire China-based peptide manufacturer GL Biochem, which it believes will create a dominant force in the non-GMP segment of the market.
3M’s drug delivery unit believes its new plasma coating and face seal valve pMDI technologies help protect APIs and will mean that more drugs can be delivered via inhalation.
CMO Kemwell is receiving technical assistance from Boehringer Ingelheim for the construction of its new biotech facility, which is designed to marry European technology with Indian low cost manufacturing.
Ireland’s API manufacturing sector suffered a blow on Friday with Corden Pharmachem’s announcement that it is phasing-out manufacturing at its facility in Little Island, Cork.
PRWT Services’ acquisition of Merck & Co’s API facility helped it post a 120 per cent increase in revenues and $8.9m (€6.4m) net income in Q1 2009, overturning a loss recorded the previous year.
3M Drug Delivery Technologies has expanded its respiratory drug delivery system offering with its Taper DPI which, it claims, makes carrier compounds unnecessary and will help drug formulators save millions.
US contract services group CoreRx has unveiled plans to purchase a new manufacturing site in Hillsborough County, Florida, according to a report in the Tampa Bay Business Journal.
US Instrument specialist Mocon has launched Pac Check 650 EC, a packaging headspace analyser that, it says, can help pharma manufacturers find the right oxygen/carbon dioxide balance to support shelf life and drug efficacy goals.
Genomatica claims it can process 1,4-butanediol (BDO), a precursor in pharmaceutical production, with 99 per cent purity from renewable feedstocks, removing the need to rely on crude oil.
At BIO 2009 Symyx was promoting its new CDMO offering, which it believes meets a “real need in the industry” and can save clients time and materials by leveraging its prior knowledge.
GE Healthcare hopes its new modular validation platform (MVP) will change the way drugmakers think about how they create new plants and bring existing manufacturing facilities up to code.
The ICH has published a question and answer (Q&A) document to clarify some of the common issues encountered by pharma companies implementing Q8, Q9 and Q10 guidelines.
Sparta Systems is establishing operations in Hong Kong as part of efforts to expand in Asia-Pacific (APAC), where it believes there is a growing market for quality and compliance management.
German glass making giant Gerresheimer has opened a new packaging plant in Danyang, China, further indicating its plans to grow in the world’s fifth largest pharmaceutical market.
Contracting giant Patheon has started legal action to restrict the voting rights of private equity group JLL Holdings, in the latest move of an increasingly acrimonious takeover battle.
At BIO 2009 Cobra Biomanufacturing explained to Outsourcing-Pharma its maxXpress service, its thoughts on expanding to commercial scale and the recent deal with KAHR Medical.
Neuland has posted a 35 per cent growth in operating profits in its 2008 financial year, despite the pricing pressures and economic environment that have affected the industry.
CMO Richter-Helm BioLogics has achieved a 60 per cent increase in yield using technology from Upfront Chromatography, which demonstrated its system at BIO 2009.
Peru’s National Center for Quality Control (CNCC) has attained ISO/IEC 17025:2005 accreditation, furthering its safety efforts and becoming one of the few Latin American countries to achieve this.
Portuguese contract manufacturing organisation (CMO) Hovione plans to invest €2m ($3m) in a new R&D unit in the capital Lisbon, as expansion space at its active pharmaceutical ingredient (API) plant in Loures is limited.
